NCT00073502 - Phase II Study of Single Agent OSI-7904L in Patients With Gastric or Gastroesophageal (GEJ) Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2003

Study Completion Date

October 31, 2003

Conditions

Gastroesophageal AdenocarcinomaGastric Adenocarcinoma

Interventions

DRUG

OSI-7904L

Trial Locations (11)

University of Pennsylvania Cancer Center, Philadelphia

MD Anderson Cancer Center, Houston

University of Utah, Huntsman Cancer Institute, Salt Lake City

Dept Internal Medicine Gastrointestinal Oncology Unit, B-3000 Leuven

Bristol Haematology & Oncology Centre, Bristol

ICRF Medical Oncology Unit, Oxford

Deanesly Centre, Wolverhampton

NICCTU, East Podium, C-Floor, Belfast

Beatson Oncology Centre, Glasgow

Cookridge Hospital, Leeds

Department of Medical Oncology, Manchester